The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kihara James since 2022.
This trader's CIK number is 1816160.
At the time of last reporting, Kihara James was the PRINCIPAL ACCOUNTING OFFICER of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ACAD | 0 | $0 | 7,925 | $152,758 | 7,588 | $0 |
| 2024 | ACAD | 0 | $0 | 7,663 | $134,609 | 14,865 | $0 |
| 2023 | ACAD | 0 | $0 | 17,506 | $412,497 | 20,196 | $0 |
| 2022 | ACAD | 0 | $0 | 1,384 | $36,270 | 3,817 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | ACAD | Sale | 4,000 | 22.50 | 90,000 |
| 2025-05-01 | ACAD | Option Ex | 2,596 | .00 | 0 |
| 2025-05-02 | ACAD | Sale | 1,327 | 14.60 | 19,374 |
| 2025-04-08 | ACAD | Sale | 1,028 | 14.82 | 15,234 |
| 2025-04-05 | ACAD | Option Ex | 2,010 | .00 | 0 |
| 2025-03-26 | ACAD | Sale | 1,095 | 17.05 | 18,669 |
| 2025-03-25 | ACAD | Option Ex | 2,142 | .00 | 0 |
| 2025-02-23 | ACAD | Option Ex | 840 | .00 | 0 |
| 2025-02-24 | ACAD | Sale | 475 | 19.96 | 9,481 |
| 2024-11-19 | ACAD | Sale | 4,073 | 16.81 | 68,467 |
| 2024-11-17 | ACAD | Option Ex | 7,930 | .00 | 0 |
| 2024-05-02 | ACAD | Sale | 1,326 | 16.94 | 22,462 |
| 2024-05-01 | ACAD | Option Ex | 2,596 | .00 | 0 |
| 2024-04-07 | ACAD | Option Ex | 1,489 | .00 | 0 |
| 2024-04-08 | ACAD | Sale | 1,790 | 17.87 | 31,987 |
| 2024-04-05 | ACAD | Option Ex | 2,010 | .00 | 0 |
| 2024-02-26 | ACAD | Sale | 474 | 24.67 | 11,693 |
| 2024-02-23 | ACAD | Option Ex | 840 | .00 | 0 |
| 2023-12-15 | ACAD | Sale | 2,000 | 28.30 | 56,600 |
| 2023-11-20 | ACAD | Sale | 1,985 | 22.64 | 44,940 |
| 2023-11-17 | ACAD | Option Ex | 3,964 | .00 | 0 |
| 2023-09-15 | ACAD | Sale | 2,000 | 25.88 | 51,760 |
| 2023-06-15 | ACAD | Sale | 2,000 | 24.15 | 48,300 |
| 2023-06-15 | ACAD | Sale | 2,000 | 24.15 | 48,300 |
| 2023-05-17 | ACAD | Option Ex | 11,894 | .00 | 0 |
| 2023-05-17 | ACAD | Sale | 5,947 | 22.50 | 133,807 |
| 2023-04-10 | ACAD | Sale | 523 | 18.14 | 9,487 |
| 2023-04-07 | ACAD | Option Ex | 1,489 | .00 | 0 |
| 2023-04-05 | ACAD | Option Ex | 2,009 | .00 | 0 |
| 2023-04-06 | ACAD | Sale | 701 | 18.16 | 12,730 |
| 2023-02-23 | ACAD | Option Ex | 840 | .00 | 0 |
| 2023-02-24 | ACAD | Sale | 350 | 18.78 | 6,573 |
| 2022-04-07 | ACAD | Option Ex | 2,977 | .00 | 0 |
| 2022-04-08 | ACAD | Sale | 1,025 | 27.05 | 27,726 |
| 2022-02-23 | ACAD | Option Ex | 840 | .00 | 0 |
| 2022-02-23 | ACAD | Sale | 359 | 23.80 | 8,544 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kihara James (PRINCIPAL ACCOUNTING OFFICER of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.